Federal Reserve Significantly Reduces Treasury Bill Purchases Again
On May 14, the Federal Reserve announced on Wednesday that it will purchase approximately $10 billion in Treasury bills during this period. This move reflects a further slowdown of the program aimed at lowering short-term financing costs by supplementing reserves in the financial system. According to the New York Fed's official website, its Open Market Trading Desk plans to conduct the aforementioned Reserve Management Purchases (RMP) during the monthly period ending June 11, along with approximately $16.3 billion in reinvestment purchases during the same period. The Federal Reserve unexpectedly halted the reduction of its balance sheet, known as quantitative tightening, at the end of 2025, and instead began injecting liquidity back into the financial system by purchasing Treasury bills maturing within one year. (Dongxin News Agency)
Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.
You may also like
BNP Paribas gives Microsoft (MSFT.US) a "Buy" rating: Azure price increases will be gradually implemented after contract renewals, and a deal with SpaceX may be announced soon.
BNP Paribas has rated Microsoft as "Buy" with a target price of $549.
Iranian President will head to New York for UN meeting
"Big Short" Burry opens a position in QXO (QXO.US), betting on building products integration and undervaluation; stock price rises over 7%
Investor Michael Burry disclosed that he has purchased common and preferred shares of QXO (QXO.US), a building products company, citing its integration strategy and the currently depressed stock price. The stock surged 7.2% on Monday.
700,000 new elderly patients join, Eli Lilly (LLY.US) dominates 70%: The first Medicare weight loss drug coverage report released
Dave Ricks, CEO of Eli Lilly (LLY.US), said in an interview on Monday that since Medicare began coverage for obesity drugs in July, 700,000 new elderly patients have started using GLP-1 medications.
